Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Brage

Orthopaedic Surgery Seattle, WA Medical Doctor

NPI 1194728709 CMS profile 281078

908 Jefferson St, Box 359799, Seattle, WA 98104

Open in the dashboard

General payments

$496,382

283 records reported · program years 2019–2025

Research payments

$12,420

Paid to them · 15 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$11,109 paid to institutions, not to them · program years 2021–2023

Through program year 2025, Michael Brage of Seattle, WA is reported in the CMS Open Payments database as having received $496,382 across 283 general payments and $12,420 in research payments paid to them. Separately, studies naming them as principal investigator received $11,109 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $56,506 37
2024 General $78,689 48
2023 General $101,985 36
2022 General $115,576 66
2021 General $45,496 20
2020 General $37,863 20
2020 Research $3,464 6
2019 General $60,268 56
2019 Research $8,956 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Brage
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Michael Brage were reported at $56,506. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Michael Brage Orthopaedic Surgery median Middle half National median
2019 $60,268 $644 $140–$2,844 $163
2020 $37,863 $312 $75–$1,860 $114
2021 $45,496 $520 $117–$2,495 $132
2022 $115,576 $598 $128–$2,731 $149
2023 $101,985 $461 $128–$2,264 $160
2024 $78,689 $497 $134–$2,475 $164
2025 $56,506 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Paragon 28, Inc. $334,310 141 payments
  2. Stryker Corporation $62,783 54 payments
  3. Osteomed LLC $26,065 11 payments
  4. restor3d, inc. $20,258 16 payments
  5. Wright Medical Technology, Inc. $19,090 21 payments
  6. Acumed LLC $13,850 7 payments
  7. Integra LifeSciences Corporation $7,904 16 payments
  8. Ascension Orthopedics, Inc. $6,938 7 payments
  9. Bioventus LLC $4,713 1 payment
  10. DePuy Synthes Sales Inc. $349 8 payments
  11. Other $123 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $249,589 76 payments
  2. Consulting Fee $196,018 46 payments
  3. Travel and Lodging $33,321 84 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $12,418 10 payments
  5. Food and Beverage $5,036 67 payments
Products named General payments · program years 2019–2025
  1. PORTFOLIO $194,001 58 payments
  2. Product Portfolio $84,105 20 payments
  3. INFINITY $55,990 20 payments
  4. INBONE $34,843 14 payments
  5. PROPHECY $24,828 7 payments
  6. INVISION $21,135 6 payments
  7. EXT-ExtremiLock Ankle $14,798 7 payments
  8. CADENCE ANKLE REPLACEMENT SYSTEM $14,342 22 payments
  9. SALTO TALARIS TOTAL ANKLE PROSTHESIS $14,342 22 payments
  10. PANTA NAIL $14,306 21 payments
  11. Other $102,711 144 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Integra LifeSciences Corporation $12,420 15 payments

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

32

Median for Orthopedic Surgery: 203

Drug cost

$331

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 14 $269
Meloxicam Generic 18 $62

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 63 billing codes

Paid by Medicare

$70,210

Medicare's payments for the services billed

Medicare patients

228

Average age 72

Services billed

462

140 women, 88 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 69%
High blood pressure 58%
Depression 29%
Osteoporosis 19%
Diabetes 17%
Chronic kidney disease 17%
Ischemic heart disease 16%
Atrial fibrillation 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

298 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record